Patents Assigned to TAVOTEK BIOTHERAPEUTICS (HONG KONG) LIMITED
  • AGENTS THAT INTERFERE WITH IL-1BETA RECEPTOR SIGNALLING
    Publication number: 20230068783
    Abstract: The present disclosure relates to antibodies that specifically bind and neutralize interleukin-1? (IL-1?), and to the use of such antibodies for the therapeutic treatment of IL-1?-mediated diseases and disorders.
    Type: Application
    Filed: July 9, 2020
    Publication date: March 2, 2023
    Applicant: TAVOTEK BIOTHERAPEUTICS (HONG KONG) LIMITED
    Inventors: Di ZHANG, Susan TAM, Minseon CHO, Lihua SHI, Man-Cheong FUNG